245 related articles for article (PubMed ID: 28222634)
21. Repetitive infusion of levosimendan in patients with chronic heart failure: a meta-analysis.
Yi GY; Li JX; Zhang J; Niu LL; Zhang CY
Med Sci Monit; 2015 Mar; 21():895-901. PubMed ID: 25811545
[TBL] [Abstract][Full Text] [Related]
22. Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy.
Flevari P; Parissis JT; Leftheriotis D; Panou F; Kourea K; Kremastinos DT
Am J Cardiol; 2006 Dec; 98(12):1641-5. PubMed ID: 17145226
[TBL] [Abstract][Full Text] [Related]
23. Intermittent levosimendan infusions in advanced heart failure: favourable effects on left ventricular function, neurohormonal balance, and one-year survival.
Malfatto G; Della Rosa F; Villani A; Rella V; Branzi G; Facchini M; Parati G
J Cardiovasc Pharmacol; 2012 Nov; 60(5):450-5. PubMed ID: 22932705
[TBL] [Abstract][Full Text] [Related]
24. Value of IGF-I levels in the evaluation of response to treatment with levosimendan in patients with severe heart failure.
Işık S; Cetin M; Ciçekçioğlu H; Uçar O; Çetin ZG; Ozuğuz U; Bakır F; Berker D; Güler S
Anadolu Kardiyol Derg; 2011 Sep; 11(6):523-9. PubMed ID: 21821501
[TBL] [Abstract][Full Text] [Related]
25. Acute effects of levosimendan on mitral regurgitation and diastolic function in patients with advanced chronic heart failure.
Branzi G; Malfatto G; Villani A; Ciambellotti F; Revera M; Giglio A; Rosa FD; Facchini M; Parati G
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):662-8. PubMed ID: 20613551
[TBL] [Abstract][Full Text] [Related]
26. Effects of levosimendan on heart failure in normotensive patients: does loading dose matter?
Palmerini E; Söderberg S; Mondillo S; Favilli R; Lunghetti S
Acute Card Care; 2015 Mar; 17(1):14-9. PubMed ID: 25806830
[TBL] [Abstract][Full Text] [Related]
27. Levosimedan improves hemodynamics functions without sympathetic activation in severe heart failure patients: direct evidence from sympathetic neural recording.
Despas F; Trouillet C; Franchitto N; Labrunee M; Galinier M; Senard JM; Pathak A
Acute Card Care; 2010 Mar; 12(1):25-30. PubMed ID: 19929264
[TBL] [Abstract][Full Text] [Related]
28. Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.
Duman D; Palit F; Simsek E; Bilgehan K; Sacide A
Can J Cardiol; 2009 Oct; 25(10):e353-6. PubMed ID: 19812809
[TBL] [Abstract][Full Text] [Related]
29. Myocardial efficiency during levosimendan infusion in congestive heart failure.
Ukkonen H; Saraste M; Akkila J; Knuuti J; Karanko M; Iida H; Lehikoinen P; Någren K; Lehtonen L; Voipio-Pulkki LM
Clin Pharmacol Ther; 2000 Nov; 68(5):522-31. PubMed ID: 11103755
[TBL] [Abstract][Full Text] [Related]
30. Early experience with Levosimendan in children with ventricular dysfunction.
Namachivayam P; Crossland DS; Butt WW; Shekerdemian LS
Pediatr Crit Care Med; 2006 Sep; 7(5):445-8. PubMed ID: 16885788
[TBL] [Abstract][Full Text] [Related]
31. Duration of the beneficial effects of levosimendan in decompensated heart failure as measured by echocardiographic indices and B-type natriuretic peptide.
McLean AS; Huang SJ; Nalos M; Ting I
J Cardiovasc Pharmacol; 2005 Dec; 46(6):830-5. PubMed ID: 16306809
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of levosimendan in patients with chronic heart failure: Does rhythm matter?
Yontar OC; Yilmaz MB; Yalta K; Tandoğan I
Anadolu Kardiyol Derg; 2010 Aug; 10(4):310-6. PubMed ID: 20693125
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of levosimendan in patients with acute heart failure.
Fedele F; D'Ambrosi A; Bruno N; Caira C; Brasolin B; Mancone M
J Cardiovasc Pharmacol; 2011 Oct; 58(4):363-6. PubMed ID: 21697728
[TBL] [Abstract][Full Text] [Related]
34. Assessment of quality of life using three activity questionnaires in heart failure patients after monthly, intermittent administration of levosimendan during a six-month period.
Papadopoulou EF; Mavrogeni SI; Dritsas A; Cokkinos DV
Hellenic J Cardiol; 2009; 50(4):269-74. PubMed ID: 19622496
[TBL] [Abstract][Full Text] [Related]
35. [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children].
Prijić S; Rakić S; Nikolić L; Jovicić B; Stajević M; Vukomanović V; Kosutić J
Vojnosanit Pregl; 2011 Nov; 68(11):979-84. PubMed ID: 22191317
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy and safety of intravenous levosimendan compared with dobutamine in decompensated heart failure].
Wang L; Cui L; Wei JP; Li GP; Qi GX; Hao YM; Wang WZ; Li HM; Liu J; Jiang DJ; Zhang YD
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jun; 38(6):527-30. PubMed ID: 21033135
[TBL] [Abstract][Full Text] [Related]
37. A 6-month follow-up of intermittent levosimendan administration effect on systolic function, specific activity questionnaire, and arrhythmia in advanced heart failure.
Mavrogeni S; Giamouzis G; Papadopoulou E; Thomopoulou S; Dritsas A; Athanasopoulos G; Adreanides E; Vassiliadis I; Spargias K; Panagiotakos D; Cokkinos DV
J Card Fail; 2007 Sep; 13(7):556-9. PubMed ID: 17826646
[TBL] [Abstract][Full Text] [Related]
38. Effect of levosimendan on E/E' ratio in patients with ischemic heart failure.
Duygu H; Ozerkan F; Nalbantgil S; Zoghi M; Akilli A; Akin M; Nazli C; Ergene O
Int J Cardiol; 2008 Jan; 123(2):201-3. PubMed ID: 17316845
[TBL] [Abstract][Full Text] [Related]
39. [The effect of levosimendan and dobutamine treatment on QT dispersion in patients with decompensated heart failure: a prospective study].
Paksoy F; Ulaş T; Tursun I; Dal MS; Oztekin E; Borlu F
Anadolu Kardiyol Derg; 2012 Feb; 12(1):16-22. PubMed ID: 22214738
[TBL] [Abstract][Full Text] [Related]
40. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
Cleland JG; Takala A; Apajasalo M; Zethraeus N; Kobelt G
Eur J Heart Fail; 2003 Jan; 5(1):101-8. PubMed ID: 12559222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]